Patents Assigned to Atlantic Pharmaceutical Products, Ltd.
  • Patent number: 5063064
    Abstract: The invention is directed to a composition and a method for preparing the same which composition inhibits or destroys unicellular living organisms. The composition is effective as a spermicide and also in combating sexually transmitted diseases and as an antiseptic agent. The composition of the invention comprises lithium and ionic or ionizable fluorine, for example, lithium fluoride. A suitable excipient such as KATHON may also be present. The invention may, for example, comprise lithium fluoride and a spermicidal agent, such as a quaternary ammonium compound, for example, benzalkonium chloride.
    Type: Grant
    Filed: September 20, 1988
    Date of Patent: November 5, 1991
    Assignee: Atlantic Pharmaceutical Products Ltd.
    Inventors: Pierre Bourbon, Pierre Lagny, Pierre Billot
  • Patent number: 4917901
    Abstract: The inventive composition comprises an active ingredient, for example a quaternary ammonium compound, which active ingredient is capable of inhibiting or destroying a unicellular living organism, such as spermatazoa, bacteria or virus. The active ingredient is combined in a synergistic amount with an activating ingredient capable of inhibiting or destroying the enzymes associated with the unicellular organism. The activating ingredient may be capable of releasing fluoride ions, for example, an inorganic fluoride compound. The composition according to the invention is useful, for example, as a spermicide, or as an antibiotic, or as an anti-STD preparation for local or topical application.
    Type: Grant
    Filed: May 22, 1987
    Date of Patent: April 17, 1990
    Assignee: Atlantic Pharmaceutical Products, Ltd.
    Inventors: Pierre Bourbon, Pierre Lagny, Pierre Billot